Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.4395
+0.0050 (1.16%)
Oct 9, 2026, 3:48 PM EST
Vaxart Market Cap
Vaxart has a market cap or net worth of $106.88 million as of October 9, 2026. It is the 25,048th most valuable company in the world and the 4,075th biggest in the United States. Its market cap has increased by 36.31% in one year.
Market Cap
106.88M
Enterprise Value
55.45M
Revenue
243.07M
Global Rank
Country Rank
#4,075 United States
PE Ratio
2.68
ChartMarket Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 106.88M, an increase of 77.11%. That is a compound annual growth rate of 6.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 106.88M | 28.58% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 285.63M |
| Northwest Biotherapeutics | 249.02M |
| Glorywin Entertainment Group | 234.77M |
| BetterLife Pharma | 121.81M |
| HST Global | 99.00M |
| Nuo Therapeutics | 60.54M |
| Sangamo Therapeutics | 58.00M |
| ProText Mobility | 57.14M |